Gastroesophageal reflux disease
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Synonyms and keywords: GERD, GORD, gastroesophageal reflux, oesophageal reflux, peptic esophagitis, esophageal reflux.
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
Gastroesophageal reflux disease is defined as chronic symptoms due to damage to the esophageal mucosa as a result of abnormal reflux of acidic stomach contents into the esophagus[1]. This is commonly due to transient or permanent changes in the barrier between the esophagus and the stomach. This can be due to incompetence of the lower esophageal sphincter (LES), transient LES relaxation, impaired expulsion of gastric reflux from the esophagus, or a hiatal hernia. Chronic GERD is associated with an increased risk of Barrett’s esophagus which is a premalignant condition of the esophageal mucosa which is in turn associated with an increased risk of adenocarcinoma of the esophagus.
Historical Perspective
GERD is believed to be first described and treated by the ancient Egyptians according to the papyrus which was discovered by Edwin Smith at Thebes. The esophagus itself was named by the ancient Greeks. Friedenwald and Feldman described the symptoms of GERD in 1925. Robbins and Jankelson used the radiological procedures to observe GERD in 1926.
Classification
GERD can be classified based on the endoscopic appearance of the esophageal mucosa and the clinical presentation of the disease.
Pathophysiology
Pathophysiology of GERD depends on several mechanisms that lead to the retrograde movement of the acidic content of the stomach to the esophagus. These mechanisms include transient lower esophageal sphincter relaxation, hypotensive lower esophageal sphincter, hiatal hernia, and prolongedesophageal acid clearance.
Causes
Common causes of GERD include obesity, autonomic neuropathy, systemic sclerosis, esophageal achalasia, and hiatus hernia. Other causes of GERD include hypochlorhydria, hypercalcemia, and Zollinger-Ellison syndrome.
Differentiating Gastroesophageal reflux disease overview from Other Diseases
GERD must be differentiated from other diseases like gastritis, peptic ulcer, crohn’s disease, gastric adenocarcinoma, and gastrinoma.
Epidemiology and Demographics
The prevalence of GERD in USA and Europe ranges from 10,000 to 20,000 per 100,000 people. The incidence of GERD increases with age especially above 40 years.
Risk Factors
Common risk factors of GERD include smoking, obesity, pregnancy, alcohol binge drinking, and medications like the anticholinergic drugs. Other risk factors include some kinds of food like spicy food and bad eating habits like eating large meals.
Screening
There is insufficient evidence to recommend routine screening for GERD.
Natural History, Complications, and Prognosis
If left untreated, 20% of patients with GERD may progress to develop esophageal stricture due to excessive acid in the lower esophagus. Complications of GERD include barrett’s esophagus, erosive esophagitis, esophageal ulcer, and esophageal adenocarcinoma. Prognosis of GERD is good with the appropriate treatment.
Diagnosis
History and Symptoms
Common symptoms of GERD include heart burn, regurgitation, and dysphagia. A positive history of nausea, vomiting, and regurgitation is suggestive of GERD. Other symptoms of GERD include chest pain, cough, and odynophagia.
Physical Examination
Patients with GERD usually appear ill due to the pain. Common physical examination include hoarseness of voice, laryngitis, otitis media, and lung wheezes.
Laboratory Findings
Laboratory findings consistent with diagnosis of GERD is the presence of acidic reflux in the esophagus through the ambulatory reflux monitoring.
Electrocardiogram
There are no EKG findings associated with GERD. However, EKG can be performed to exclude the cardiac causes of chest pain that can be presented in cases of atypical GERD.
X ray
X ray imaging suggestive for associated problems with GERD include free acid reflux, esophagitis with scarring, strictures, and barrett’s esophagus.
CT scan
There are no CT findings associated with GERD.
MRI scan
There are no MRI findings associated with GERD.
Echocardiography or ultrasound
There are no ultrasound findings associated with GERD.
Other Imaging Studies
There are no other imaging findings associated with GERD. However, endoscopy may be used in screening for the complications associated with chronic GERD like barrett’s esophagus.
Other Diagnostic Studies
There are no other diagnostic studies associated with GERD.
Treatment
Medical Therapy
The mainstay treatment of GERD is lifestyle modifications which include weight loss, elevating head of the bed and no eating before going sleep. The pharmacologic medical therapy is recommended among patients with persistent GERD despite following the lifestyle modifications. Antacids, histamine receptor antagonists, proton pump inhibitors, and prokinetics medications are used in treatment of GERD.
Surgery
Surgery is not the first-line treatment option for patients with GERD. Surgery is usually reserved for patients with either chronic GERD, high volume of acid reflux, non-compliant medical therapy, the presence of large hiatal hernia, or with upper respiratory manifestations as hoarseness of voice and laryngitis. The nissen fundoplication is the operation of choice in patients with GERD.
Prevention
Effective measures for the primary prevention of GERD include avoiding food that worsens the symptoms, smoking cessation, weight loss, eating frequent meals, and head raising of the bed while sleeping.
References
- ↑ DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1999;94:1434-42. PMID 10364004.
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
GERD is believed to be first described and treated by the ancient Egyptians according to the papyrus which was discovered by Edwin Smith at Thebes. The esophagus itself was named by the ancient Greeks. Friedenwald, and Feldman described the symptoms of GERD in 1925. Robbins and Jankelson used the radiological procedures to observe GERD in 1926.
Historical Perspective
- The esophagus was first named by the ancient Greeks as “oisophagos” at which “oiso” means carry and “phagema” means food.[1]
- In 1541, Gyudon put the first description of the esophagus and its function.
- In 1704, Anton Maria Valsalva published an article where he described the lower esophageal sphincter (LES). The LES was first named as cardiac sphincter as it is very near to the heart.
- In 1862, the American Egyptologist Edwin Smith discovered a papyrus at Thebes. This papyrus, which was named after him, contain 48 cases of different illnesses and their treatment. In 1930, the Edwin Smith papyrus was translated by Henry Breasted. Among the 48 cases, the case number 28 was titled with “Instructions concerning a wound in his throat” which was most probably a case of GERD.
- In 1925, Friedenwald and Feldman described the presenting symptoms of GERD. They associated between the symptoms of GERD and the presence of hiatus hernia.
- In 1926, Robbins and Jankelson used the radiological procedures to observe GERD.
References
- ↑ Granderath, Frank A.; Kamolz, Thomas; Pointner, Rudolph (2006). doi:10.1007/3-211-32317-1. Missing or empty
|title=(help)
Classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
GERD can be classified based on the endoscopic appearance of the esophageal mucosa and the clinical presentation of the disease.
Classification
- GERD can be classified based on the endoscopic appearance of the esophageal mucosa into two subtypes:[1]
- Erosive GERD
- Non-erosive GERD
- GERD can be classified based on the clinical presentation into two types:[2]
- Typical GERD
- Atypical GERD
References
- ↑ Chang P, Friedenberg F (2014). “Obesity and GERD”. Gastroenterol Clin North Am. 43 (1): 161–73. doi:10.1016/j.gtc.2013.11.009. PMC 3920303. PMID 24503366.
- ↑ Richter JE (1996). “Typical and atypical presentations of gastroesophageal reflux disease. The role of esophageal testing in diagnosis and management”. Gastroenterol Clin North Am. 25 (1): 75–102. PMID 8682579.
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
Pathophysiology of GERD depends on several mechanisms that lead to the retrograde movement of the acidic content of the stomach to the esophagus. These mechanisms include transient lower esophageal sphincter relaxation, hypotensive lower esophageal sphincter, hiatal hernia, and prolonged esophageal acid clearance.
Pathophysiology
Normal physiology of the food motility through the esophagus
- The esophagus is a part of the gastrointestinal tract which is responsible of moving the food from the mouth to the rectum.[1]
- The esophagus has anti-reflux barrier which prevents the return of the acidic contentof the stomach back to the esophagus. The anti-reflux barrier consists of the lower esophageal sphincter (LES) and the related part of the diaphragm.
- The lower esophageal sphincter is contracting smooth muscle at the end of the esophagus responsible for the food passage to the stomach. LES has high pressure tone which helps keeping it a strong barrier between the esophagus and the stomach.

Pathogenesis
- Pathogenesis of GERD depends on various mechanisms that lead to the reflux of the gastric acidic contents into the esophagus.
- Several mechanisms impair the anti-reflux barrier and cause esophageal dysmotility. These mechanisms include the following:[2][3]
- Transient lower esophageal sphincter relaxations
- Hypotensive lower esophageal sphincter
- Hiatus hernia
- Impaired esophageal acid clearance
- Delayed gastric emptying
Transient lower esophageal sphincter relaxations
- Transient lower esophageal sphincter relaxations is considered the main mechanism of GERD development in most of the patients. It occurs alongside a normal LES and more common with obesity. [4]
- Distension of the stomach worsens the case of transient lower esophageal sphincter relaxation. The diaphragm is also affected by the sphincter relaxation leading to diaphragm inhibition. [5]
- Some of the GERD patients have hypotensive lower esophageal sphincter which leads to retrograde movement of the gastric content into the esophagus.
Hiatal hernia
- A hiatal hernia occurs as part of the stomach is dislocated into the chest. This dislocation leads to placement of the LES above the diaphragm impairing the acid clearance.[6]
- Increase the exposure of the lower esophagus due to a hiatal hernia plays a big role in the pathogenesis of GERD.
Impaired mucosal resistance
- The esophagus has pre-epithelial and epithelial defensive mechanisms against the acidic components that can lead to esophageal injury. However, these defensive mechanisms are limited and weak to stand against injury in case of excessive acid exposure.
- In case of an excessive increase of the noxious agents more than the ability of the mucosal defensive mechanism to eliminate them, mucosal injury occurs and GERD develops.
- The gastric acid leads to erosion of the esophageal mucosa and destruction of the intercellular junctions which leads to increase cellular permeability. The increase in the cellular permeability is proved by the dilation of the intercellular spaces and explains the typical symptoms (e.g, heartburn) of GERD.
Associated Conditions
The most important conditions and diseases associated with GERD include the following: [7][8]
Gross pathology
Findings in gross pathology of GERD include the following:
- Erythematous esophageal mucosa
- Erosions
- Ulcerations in severe cases
Microscopic pathology
Biopsies can be performed during gastroscopy and these may show:
- Edema and basal hyperplasia (non-specific inflammatory changes)
- Lymphocytic inflammation (non-specific)
- Neutrophilic inflammation (usually due to reflux or Helicobacter gastritis)
- Eosinophilic inflammation (usually due to reflux)
- Goblet cell intestinal metaplasia or Barrett’s esophagus.
- Elongation of the papillae
- Thinning of the squamous cell layer
- Dysplasia or pre-cancer.
- Carcinoma.

References
- ↑ Stein HJ, DeMeester TR (1992). “Outpatient physiologic testing and surgical management of foregut motility disorders”. Curr Probl Surg. 29 (7): 413–555. PMID 1606845.
- ↑ Storr M, Meining A, Allescher HD (2000). “Pathophysiology and pharmacological treatment of gastroesophageal reflux disease”. Dig Dis. 18 (2): 93–102. doi:10.1159/000016970. PMID 11060472.
- ↑ De Giorgi F, Palmiero M, Esposito I, Mosca F, Cuomo R (2006). “Pathophysiology of gastro-oesophageal reflux disease”. Acta Otorhinolaryngol Ital. 26 (5): 241–6. PMC 2639970. PMID 17345925.
- ↑ Fisher BL, Pennathur A, Mutnick JL, Little AG (1999). “Obesity correlates with gastroesophageal reflux”. Dig Dis Sci. 44 (11): 2290–4. PMID 10573376.
- ↑ Kahrilas PJ, Shi G, Manka M, Joehl RJ (2000). “Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distention in reflux patients with hiatal hernia”. Gastroenterology. 118 (4): 688–95. PMID 10734020.
- ↑ Richter J (1999). “Do we know the cause of reflux disease?”. Eur J Gastroenterol Hepatol. 11 Suppl 1: S3–9. PMID 10443906.
- ↑ Morse CA, Quan SF, Mays MZ, Green C, Stephen G, Fass R (2004). “Is there a relationship between obstructive sleep apnea and gastroesophageal reflux disease?”. Clin. Gastroenterol. Hepatol. 2 (9): 761–8. PMID 15354276.
- ↑ Kasasbeh A, Kasasbeh E, Krishnaswamy G (2007). “Potential mechanisms connecting asthma, esophageal reflux, and obesity/sleep apnea complex–a hypothetical review”. Sleep Med Rev. 11 (1): 47–58. doi:10.1016/j.smrv.2006.05.001. PMID 17198758.
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
Common causes of GERD include obesity, autonomic neuropathy, systemic sclerosis, esophageal achalasia, and hiatus hernia. Other causes of GERD include hypochlorhydria, hypercalcemia, and Zollinger-Ellison syndrome.
Causes
Life threatining causes
- Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.There are no life-threatening causes of GERD.
Common causes
Common causes of GERD include the following:[1]
- Obesity
- Hereditary sensory and autonomic neuropathy type 1B
- Esophageal achalasia
- Ibuprofen lysine
- Hiatus hernia
- Pharyngeal pouch
Less common causes
Less common causes of GERD include the following:
- Hypochlorhydria
- Hypercalcemia, which can increase gastrin production, leading to increased acidity.
- Zollinger-Ellison syndrome, which can be present with increased gastric acidity due to gastrin production.
- Scleroderma and systemic sclerosis, which can feature esophageal dysmotility.
Causes by Organ System
| Cardiovascular | No underlying causes |
| Chemical/Poisoning | No underlying causes |
| Dental | No underlying causes |
| Dermatologic | No underlying causes |
| Drug Side Effect | Apremilast, febuxostat, ibuprofen lysine, naproxen and esomeprazole magnesium, pirfenidone, pramipexole, ritonavir, |
| Ear Nose Throat | No underlying causes |
| Endocrine | No underlying causes |
| Environmental | No underlying causes |
| Gastroenterologic | No underlying causes |
| Genetic | No underlying causes |
| Hematologic | No underlying causes |
| Iatrogenic | No underlying causes |
| Infectious Disease | No underlying causes |
| Musculoskeletal/Orthopedic | No underlying causes |
| Neurologic | No underlying causes |
| Nutritional/Metabolic | No underlying causes |
| Obstetric/Gynecologic | No underlying causes |
| Oncologic | No underlying causes |
| Ophthalmologic | No underlying causes |
| Overdose/Toxicity | No underlying causes |
| Psychiatric | No underlying causes |
| Pulmonary | No underlying causes |
| Renal/Electrolyte | No underlying causes |
| Rheumatology/Immunology/Allergy | No underlying causes |
| Sexual | No underlying causes |
| Trauma | No underlying causes |
| Urologic | No underlying causes |
| Miscellaneous | No underlying causes |
References
- ↑ Ayazi S, Crookes P, Peyre C, (2007). “Objective documentation of the link between gastroesophageal reflux disease and obesity”. Am. J. Gastroenterol. 102 (S): 138–139.
Differentiating Gastroesophageal Reflux Disease from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
GERD must be differentiated from other diseases like gastritis, peptic ulcer, crohn’s disease, gastric adenocarcinoma, and gastrinoma.
Differentiating Gastroesophageal Reflux Disease from other Diseases
- GERD must be differentiated from other diseases such as gastritis, peptic ulcer, crohn’s disease, gastric adenocarcinoma, and gastrinoma.[1][2][3][4][5][6][7][8][9]
| Differential Diagnosis | ||||||||||||
| Disease | Cause | Symptoms | Diagnosis | Other findings | ||||||||
| Pain | Nausea & Vomiting | Heartburn | Belching or Bloating | Weight loss | Loss of Appetite | Stools | Endoscopy findings | |||||
| Location | Aggravating Factors | Alleviating Factors | ||||||||||
| GERD |
|
|
|
✔
(Suspect delayed gastric emptying) |
✔ | – | – | – | – | Other symptoms:
Complications
| ||
| Acute gastritis |
|
Food | Antacids | ✔ | ✔ | ✔ | – | ✔ | Black stools |
|
– | |
| Chronic gastritis |
|
Food | Antacids | ✔ | ✔ | ✔ | ✔ | ✔ | – | H. pylori gastritis
Lymphocytic gastritis
|
– | |
| Atrophic gastritis | Epigastric pain | – | – | ✔ | – | ✔ | ✔ | – | H. pylori
|
| ||
| Crohn’s disease | – | – | – | – | – | ✔ | ✔ |
|
|
|||
| Peptic ulcer disease |
|
|
|
|
✔ | ✔ | – | – | – | Gastric ulcers
Duodenal ulcers
|
Other diagnostic tests | |
| Gastrinoma |
|
– | – | ✔
(suspect gastric outlet obstruction) |
✔ | – | – | – | Useful in collecting the tissue for biopsy |
Diagnostic tests
| ||
| Gastric Adenocarcinoma |
|
– | – | ✔ | ✔ | ✔ | ✔ | ✔ |
|
Esophagogastroduodenoscopy
|
Other symptoms | |
| Primary gastric lymphoma |
|
– | – | – | – | – | ✔ | – | – | Useful in collecting the tissue for biopsy | Other symptoms
| |
- GERD must be differentiated from other causes of dysphagia, odynophagia and food regurgitation such as esophageal adenocarcinoma and esophageal stricture.
| Manifestations | Diagnostic tools | |
|---|---|---|
| Achalasia |
|
![]() |
| GERD |
|
![]() |
| Esophageal carcinoma |
|
![]() |
| Corckscrew esophagus |
![]() | |
| Esophageal stricture |
|
![]() |
| Plummer-Vinson syndrome | Common symptoms of Plummer-Vinson syndrome include:[17][18][19]
Less cmmon symptoms
|
Lab tests are consistent with the diagnosis of iron deficiency anemia.
Findings on an x-ray (barium esophagogram) suggestive of esophageal web/strictures associated with Plummer-Vinson syndrome appear as either:
![]() |
References
- ↑ Sugimachi K, Inokuchi K, Kuwano H, Ooiwa T (1984). “Acute gastritis clinically classified in accordance with data from both upper GI series and endoscopy”. Scand J Gastroenterol. 19 (1): 31–7. PMID 6710074.
- ↑ Sipponen P, Maaroos HI (2015). “Chronic gastritis”. Scand J Gastroenterol. 50 (6): 657–67. doi:10.3109/00365521.2015.1019918. PMC 4673514. PMID 25901896.
- ↑ Sartor RB (2006). “Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis”. Nat Clin Pract Gastroenterol Hepatol. 3 (7): 390–407. doi:10.1038/ncpgasthep0528. PMID 16819502.
- ↑ Sipponen P (1989). “Atrophic gastritis as a premalignant condition”. Ann Med. 21 (4): 287–90. PMID 2789799.
- ↑ 5.0 5.1 Badillo R, Francis D (2014). “Diagnosis and treatment of gastroesophageal reflux disease”. World J Gastrointest Pharmacol Ther. 5 (3): 105–12. doi:10.4292/wjgpt.v5.i3.105. PMC 4133436. PMID 25133039.
- ↑ Ramakrishnan K, Salinas RC (2007). “Peptic ulcer disease”. Am Fam Physician. 76 (7): 1005–12. PMID 17956071.
- ↑ Banasch M, Schmitz F (2007). “Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors”. Wien Klin Wochenschr. 119 (19–20): 573–8. doi:10.1007/s00508-007-0884-2. PMID 17985090.
- ↑ Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM (2005). “Gastric adenocarcinoma: review and considerations for future directions”. Ann Surg. 241 (1): 27–39. PMC 1356843. PMID 15621988.
- ↑ Ghimire P, Wu GY, Zhu L (2011). “Primary gastrointestinal lymphoma”. World J Gastroenterol. 17 (6): 697–707. doi:10.3748/wjg.v17.i6.697. PMC 3042647. PMID 21390139.
- ↑ Ferri, Fred (2015). Ferri’s clinical advisor 2015 : 5 books in 1. Philadelphia, PA: Elsevier/Mosby. ISBN 978-0323083751.
- ↑ 11.0 11.1 11.2 Boeckxstaens GE, Zaninotto G, Richter JE (2013). “Achalasia”. Lancet. doi:10.1016/S0140-6736(13)60651-0. PMID 23871090.
- ↑ 12.0 12.1 Napier KJ, Scheerer M, Misra S (2014). “Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities”. World J Gastrointest Oncol. 6 (5): 112–20. doi:10.4251/wjgo.v6.i5.112. PMC 4021327. PMID 24834141.
- ↑ Matsuura H (2017). “Diffuse Esophageal Spasm: Corkscrew Esophagus”. Am. J. Med. doi:10.1016/j.amjmed.2017.08.041. PMID 28943381.
- ↑ Lassen JF, Jensen TM (1992). “[Corkscrew esophagus]”. Ugeskr. Laeg. (in Danish). 154 (5): 277–80. PMID 1736462.
- ↑ Ruigómez A, García Rodríguez LA, Wallander MA, Johansson S, Eklund S (2006). “Esophageal stricture: incidence, treatment patterns, and recurrence rate”. Am. J. Gastroenterol. 101 (12): 2685–92. doi:10.1111/j.1572-0241.2006.00828.x. PMID 17227515.
- ↑ Shami VM (2014). “Endoscopic management of esophageal strictures”. Gastroenterol Hepatol (N Y). 10 (6): 389–91. PMC 4080876. PMID 25013392.
- ↑ López Rodríguez MJ, Robledo Andrés P, Amarilla Jiménez A, Roncero Maíllo M, López Lafuente A, Arroyo Carrera I (2002). “Sideropenic dysphagia in an adolescent”. J. Pediatr. Gastroenterol. Nutr. 34 (1): 87–90. PMID 11753173.
- ↑ Chisholm M (1974). “The association between webs, iron and post-cricoid carcinoma”. Postgrad Med J. 50 (582): 215–9. PMC 2495558. PMID 4449772.
- ↑ Larsson LG, Sandström A, Westling P (1975). “Relationship of Plummer-Vinson disease to cancer of the upper alimentary tract in Sweden”. Cancer Res. 35 (11 Pt. 2): 3308–16. PMID 1192404.
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
The prevalence of GERD in USA and Europe ranges from 10,000 to 20,000 per 100,000 people. The incidence of GERD increases with age especially above 40 years.
Epidemiology and Demographics
Prevalence
- In the USA and Europe, the prevalence of GERD ranges from low of 10,000 per 100,000 persons to high of 20,000 per 100,000 people. [1]
- In Asia, the prevalence of GERD is 5,000 per 100,000 people.
Incidence
- In the USA, the incidence of GERD is 5,400 per 100,000 persons.
- In Europe, the incidence of GERD is 840 per 100,000 persons.
Age
- The prevalence of GERD increases with age.
- GERD affects all age groups but it affects more the people older than 40 years.
Gender
- Men and women are affected equally by GERD.
Race
- There is no racial predilection for GERD.
References
- ↑ El-Serag HB, Sweet S, Winchester CC, Dent J (2014). “Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review”. Gut. 63 (6): 871–80. doi:10.1136/gutjnl-2012-304269. PMC 4046948. PMID 23853213.
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
Common risk factors of GERD include smoking, obesity, pregnancy, alcohol binge drinking, and medications like the anticholinergic drugs. Other risk factors include some kinds of food like spicy food and bad eating habits like eating large meals.
Risk Factors
Common risk factors
Common risk factors of GERD include the following:
- Smoking
- Obesity
- Pregnancy
- Hiatal hernia
- Scleroderma
- Drinking a lot of alcohol
- Consuming drinks that contain caffeine
- Anticholinergics (e.g. for seasickness)
- Beta blockers for high blood pressure or heart disease
- Bronchodilators for asthma
- Calcium channel blockers for high blood pressure
- Dopamine-active drugs for Parkinson’s disease
- Progestin for abnormal menstrual bleeding or birth control
- Sedatives for insomnia or anxiety
- Tricyclic antidepressants
Less common risk factors
Less common risk factors of GERD include the following:[1]
- Special kind of diet from below items:
- Spicy food
- Fried food
- Sweets
- Eating habits such as the following:
- Irregular eating
- Eating quickly
- Eating between meals
- Eating large meals
References
- ↑ Jarosz M, Taraszewska A (2014). “Risk factors for gastroesophageal reflux disease: the role of diet”. Prz Gastroenterol. 9 (5): 297–301. doi:10.5114/pg.2014.46166. PMC 4223119. PMID 25396005.
Screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
There is insufficient evidence to recommend routine screening for GERD.
Screening
There is insufficient evidence to recommend routine screening for GERD.
References
Natural History, Complications and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
If left untreated, 20% of patients with GERD may progress to develop esophageal stricture due to excessive acid in the lower esophagus. Complications of GERD include barrett’s esophagus, erosive esophagitis, esophageal ulcer, and esophageal adenocarcinoma. Prognosis of GERD is good with the appropriate treatment.
Natural History, Complications and Prognosis
Natural History
- The symptoms of GERD include heart burn, regurgitation, and dysphagia.
- If left untreated, GERD will develop to esophageal stricture which occurs in around 20% of the patients with GERD.[1]
- Esophageal stricture occur due to excessive acid in the lower of the esophagus which lead to scar formation. This scar causes narrowing of the esophagus and lead to difficulties in swallowing.
Complication
Complications that can develop as a result of GERD include the following:[2]
- Barrett’s esophagus:
- A type of dysplasia, is a precursor high-grade dysplasia, which is in turn a precursor condition for carcinoma. The risk of progression from Barrett’s to dysplasia is uncertain but is estimated to include 0.1% to 0.5% of cases, and has probably been exaggerated in the past.
- Due to the risk of chronic heart burn progressing to Barrett’s esophagus, EGD every 5 years is recommended for patients with chronic heartburn, or who take drugs for chronic GERD.
- Erosive esophagitis
- Esophageal ulcer:
- Esophageal adenocarcinoma
Prognosis
- The majority of people respond to nonsurgical measures, with lifestyle changes and medications. However, many patients need to continue to take drugs to control their symptoms.
References
- ↑ Sonnenberg A, El-Serag HB (1999). “Clinical epidemiology and natural history of gastroesophageal reflux disease”. Yale J Biol Med. 72 (2–3): 81–92. PMC 2579001. PMID 10780569.
- ↑ El-Serag HB, Graham DY, Satia JA, Rabeneck L (2005). “Obesity is an independent risk factor for GERD symptoms and erosive esophagitis”. Am J Gastroenterol. 100 (6): 1243–50. doi:10.1111/j.1572-0241.2005.41703.x. PMID 15929752.
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH






